WO2008026020A1 - Plaquette blister - Google Patents

Plaquette blister Download PDF

Info

Publication number
WO2008026020A1
WO2008026020A1 PCT/IB2006/002407 IB2006002407W WO2008026020A1 WO 2008026020 A1 WO2008026020 A1 WO 2008026020A1 IB 2006002407 W IB2006002407 W IB 2006002407W WO 2008026020 A1 WO2008026020 A1 WO 2008026020A1
Authority
WO
WIPO (PCT)
Prior art keywords
medication
blister pack
code
communication device
indicia
Prior art date
Application number
PCT/IB2006/002407
Other languages
English (en)
Inventor
Gerardus Adrianus Hoogland
Cornelis Erik Tjoa
Original Assignee
Fellgate Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fellgate Limited filed Critical Fellgate Limited
Priority to PCT/IB2006/002407 priority Critical patent/WO2008026020A1/fr
Publication of WO2008026020A1 publication Critical patent/WO2008026020A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/30—Compliance analysis for taking medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/10—Bar codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/30—Printed labels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/50—General identification or selection means using icons or symbolic figures, e.g. by a graphical representation symbolising the type of pathology or the organ by an image
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00—General identification or selection means
    • A61J2205/60—General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0076—Medicament distribution means
    • A61J7/0084—Medicament distribution means for multiple medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers

Definitions

  • This invention relates to a blister pack for storing medication units and to a method for monitoring the administration of medication.
  • the invention also relates to a method of distributing medication.
  • round tripping Another problem is known as round tripping. This is especially prevalent with HIV/AIDS medication which is often made available to resource limited countries at significantly discounted prices. A market emerges in which cheap medication from poorer countries is brought into wealthier countries where it is sold at a significant profit. Such a practice is not only damaging to pharmaceutical manufacturing companies but also to the population of the country for whom the medication was originally intended. If authorities were able to trace medication, the round-tripping market could be more effectively controlled and possibly prevented.
  • Another consequence of poor administration in hospitals and clinics is poor pharmacovigilance. Should one patient be treated by more than one health practitioner, such as two medical doctors, there is often no communication between the practitioners. One doctor may prescribe medication which interacts negatively with or diminishes the effect of another medication which has been prescribed by the second doctor.
  • the object of this invention is to provide a solution, which at least partly alleviates the abovementioned problems.
  • a blister pack including a tray defining a plurality of recesses, each recess accommodating a unit of medication, and; a cover sheet, secured to the tray to enclose the units of medication accommodated in the recesses, characterized in that the recesses accommodate more than one type of medication.
  • the invention further provides for each recess to accommodate a single unit of medication.
  • the medication units on the blister pack may be associated with a single disease, for which treatment may be curative or prophylactic, or with more than one disease, such as HIV and an opportunistic disease, for example, tuberculosis. It may therefore include the treatment of secondary diseases and/or symptoms and/or the treatment of side effects of a primary medication.
  • a disease is a common disease for which the treatment with a combination of drugs is commonly prescribed, such as tuberculosis and HIV/AIDS
  • blister packs containing all drugs prescribed in combination can be manufactured efficiently in large series on a large scale, industrial basis.
  • the invention yet further provides for the recesses to arranged in sets of one or more recesses, each set accommodating one or more units of medication to be administered within a predetermined time frame.
  • the blister sets may be arranged on the pack in groups and each group may consist of units of medication to be administered within a predetermined time frame.
  • the recess sets may further be arranged on the blister pack into groups, each group consisting of units to be taken during the course of one day. Each group may be arranged in a row on the pack and each row may further be grouped into a series. The series may represent a week or a month.
  • the cover sheet to have displayed thereon indicia associated with each set representative of a time of day when the medication of that set has to be taken.
  • the time of day may be indicated by means of a symbol for day and night which may be a sun for day and a moon for night.
  • the cover sheet may further include indicia associated with each group indicating the day of the week or of the month.
  • the label which may be printed on or adhere to the outer surface of the cover sheet or be attached to the set of medication in another manner, may further include indicia identifying each set depicted thereon, each in association with the respective set, for instance each time in an area of the cover sheet close to the cavities containing the medication units of that set.
  • the indicia represent a code representing which blister pack the set is or was a member.
  • the indicia represents the generic name of each medication unit in the set. Still further preferably, it represents the production batch of the set. Yet further preferably, it represents the expiry date of each set.
  • the indicia may also represent the date of production of the set, the name of the manufacturer, and a sequential tablet identifier.
  • the indicia may be in the form of a bar code, which may for instance be a single dimension or 2D bar code, associated with each set.
  • the bar code may be included in addition to or instead of written information.
  • the medication unit identifiers to be contained in a radio frequency transmitter arranged for transmitting a code identifying at least the blister pack.
  • the invention extends to a method of monitoring the administration of medication from a pack containing more than one type of medication unit arranged on the pack in sets of one or more units, the pack having indicia representative of each set depicted thereon, each in association with the respective set.
  • a medication set code represented by the indicia depicted in association with one of the sets of the medication is entered into an electronic communication device.
  • the entered medication set code is sent to a data centre where a database is maintained including medication set codes of sets to be administered and associated time limits.
  • Medication set codes in the database corresponding to the code received at the data centre as having been taken are marked accordingly and a warning signal is issued from the data centre to predetermined parties in response to expiration of a time limit, stored in the data centre, associated with a medication set code while the corresponding medication set code has not yet been received at the data centre.
  • the codes only need to be entered per occasion when a plurality of medication units is taken (the medication units may be taken briefly after each other, for instance because it is preferred to swallow one at a time), the effort and amount of communication required to monitor whether the drug regimen is correctly followed is substantially reduced.
  • the communication device may be a telephone. Telephones are compact, low-cost standard equipment and are widely available.
  • the telephone may be a mobile telephone incorporating a barcode reader in electronic communication with the data centre.
  • it may be a mobile telephone incorporating a digital camera, the method further comprising capturing and storing an image including the indicia by the digital camera, determining a medication set code from the indicia contained in the image as medication set code to be sent to the data centre.
  • the communication device may also be a computer enabled with a modem.
  • the data centre stores a communication device code identifying the communication device from which the medication set code is received, it can easily be verified if the medication set code is received from a person authorized to send the monitoring data.
  • the warning signal can be sent to a communication device identified by a communication device code received in association with an earlier medication set code identifying a medication set of the same pack, so that it is ensured in a simple manner that the person involved in the implementation of the drug regimen for a given patient is warned if a time limit has been missed.
  • the time limits associated with the medication set codes assigned to medication sets of the same pack may be set in response to receiving a first one of the medication set codes assigned to medication sets of that pack, so that the time limits are automatically triggered with the start of the use of a medications from a pack.
  • the authenticity of a received medication set code may be checked against reference data and subsequently an authenticity message containing a result of the authenticity check may be returned in reply to the received medication set code.
  • the authenticity message may contain a warning of non-authenticity or a confirmation of authenticity. Depending on requirements, only warnings or only confirmations may be sent.
  • each blister pack including a tray defining a plurality of recesses, each accommodating a medication unit, and a cover sheet secured to the tray to enclose the units in the recesses, the recesses accommodating more than one type of medication and being arranged on the tray in sets of one or more recesses, the cover sheet having a label including indicia representing a medication set code associated with each set,
  • the system comprising a storage space for storing blister packs, the storage space having an electronic communication device associated therewith operable to read the set code; and an administration centre including a database for storing information relating to each medication set; the communication device being operable to transmit the reading to the administration centre.
  • the stored information may include a batch number, active ingredients and expiry date. It may also include a manufacturer identifier.
  • the invention further provides for the system to include a plurality of electronic communication devices for predetermined health practitioners to transmit a reading to the administration centre and to receive a signal from the administration centre in response to the reading.
  • Each device for the predetermined health practitioners may have an identifier and the administration centre may have a means for detecting the identifier.
  • the administration centre may be operable to verify the authority of the health practitioner by receiving a password from the health practitioner's electronic communication device and then verifying that the password corresponds to the identifier detected.
  • the system may include a plurality of patient identifiers, each carried by a patient, and for the data centre to have a database for storing each patient's code, diagnosis and treatment regimen.
  • the electronic communication devices may then be operable to read a patient's identifier and to transmit the reading to the administration centre.
  • the electronic communication devices may be a mobile telephone incorporating a digital camera or a barcode scanner.
  • the administration centre may be operable to receive prescription information from the health practitioner's communication device.
  • the administration centre is also operable to verify that the medication included in the patient's prescription is compatible with any other medication, which is recorded in the patient's treatment regimen in the database, and to transmit a warning signal to the electronic communication device in response to the reading.
  • the administration centre is operable to verify that the prescribed medication is compatible with any pre-existing medical condition stored in the database. Then, the administration centre may be operable to transmit a warning signal to the health practitioner's communication device in the event of incompatibility.
  • Figure 1 is a perspective view of the front side of a blister pack in accordance with the invention.
  • Figure 2 is a perspective view of the reverse side of a blister pack in accordance with the invention.
  • Figure 3 is an overview of an example of an implementation of a method according to the invention.
  • Figure 4 is a table representing some features of an example of a database to be used in combination in a method according to the invention.
  • FIG. 5 is a schematic representation of a system for distributing medication in accordance with this invention. DETAILED DESCRIPTION OF THE INVENTION
  • a blister pack 1 is shown in Figures 1 and 2 and includes a transparent tray 3 defining a plurality of recesses 5, each accommodating a medication unit 7, and a cover sheet 9, typically an aluminium or other frangible foil sheet, secured on the tray 3 to enclose the units 7 in the recesses 5 in any conventional manner.
  • the recesses 5 are shaped and dimensioned to accommodate more than one type of medication unit 7 and are arranged on the sheet 3 in seven groups 13 or rows 13, each row 13 being associated with a week day.
  • Each row 13 is arranged into two sets 15, the first set 17 including two medication units 7.1 and 7.2 to be taken during the morning, typically with breakfast, and the second set 19 including three medication units 7.3, 7.4 and 7.5 to be taken in the evenings.
  • the cover sheet 9 to have a label 21 associated with each set 15 indicating prescribing information.
  • the prescribing information includes a sun 23, symbolizing day, and a crescent moon 25, symbolizing night.
  • the cover sheet also includes a numeral 27 between one and seven associated with each row 13 indicating the day of the week. It will be readily appreciated that no literacy is required to understand at which time of day each set of medication is to be taken. If it is wished to indicate whether or not the medication is to be taken together or not with a meal, the set may have a spoon or a crossed out spoon associated therewith depicted on the label.
  • each medication unit 7 is also labelled on the cover sheet 9 and is positioned thereon so that it is associated with the relevant medication unit 7.
  • this is depicted generically using the terms "DRUG 1", “DRUG 2" and the like.
  • a batch number 31 and an expiry date 33, associated with each group 13, are also depicted on the cover sheet 9.
  • the cover sheet 9 has a bar code 35 depicted thereon associated with each set 15.
  • the information contained in the barcode 35 includes the expiry date, active ingredient, and batch number of the set 15. It may optionally include the manufacturer's name. Instead, the barcode 35 may contain a coded reference to the expiry date, active ingredient and batch number, the code and the information to which it corresponds being stored in a database.
  • the medication unit identifiers may be contained in a radio frequency transmitter instead of or in addition to the barcode.
  • a pack 1 as shown in Figure 1 is shown in the context of means for monitoring adherence to a drug regimen.
  • a communication device 40 in the form of a mobile telephone is used for inputting a medication set code represented by the indicia 35 into the telephone 40.
  • the indicia 35 are provided in the form of a bar code that is depicted on the back of the set 17 of the medications.
  • the mobile telephone 40 may incorporate a barcode reader. Instead, the mobile telephone 40 may incorporate a digital camera with a lens 41. An image including the indicia 35 is then projected via the lens 41 on an imaging chip (not shown). The image is converted into image data representing the projected image by the digital camera. The medication set code is read by a suitable reader remote from the telephone 40 from the indicia contained in the image data.
  • the indicia may also be provided in another form, for instance in the form of humanly readable characters, if optical character recognition software is available for determining the code therefrom.
  • the medication set code that has been captured is sent to a data centre 42.
  • the supervisor also needs to provide a code identifying the patient for whom the medications in the pack 1 are intended.
  • the medication set codes 46 of the sets 19 of that pack 1 are associated to that patient code.
  • the time limits 47 for administering successive dosage sets 19 associated to that patient are then also associated to the set codes 46.
  • the medication set code as sent may be in the form of the image data containing the indicia (the determination of the medication set code is then made after transmission of the image data) or in the form of data representing the medication set code as such, which have been determined from the image data before sending.
  • the transmission of the medication set code involves sending a message to a cellular network station 43 via wireless communication represented by arrow 44 and transmission of the message via a Public Switch Telephone Network 44 to the data centre 42. This transmission may involve the use of SMS servers or other communication equipment known per se.
  • a database 45 is maintained including medication set codes 46 of sets to be administered, associated time limits 47 and data 48 indicating whether a medication set represented by a medication set code is marked as having been taken.
  • the medication set code 7385-01 has been received from the telephone 40, and in reaction thereto, the medication set code 7385-01 in the database 45 is marked as having been taken by a "1", the other medication set codes of the group 7385 still being marked with a "0" to indicate that those sets still have to be taken.
  • a warning signal is issued from the data centre 44 in response to expiration of a time limit (in this example 30 July, 8:00 PM) associated to a medication set code while the corresponding medication set code 7385-02 has not yet been received at the data centre 42.
  • the warning signal is sent to the mobile telephone 40 of supervisor 138, which has been registered as sender of a previous medication set code of the group 7385 of medication sets packed in the blister pack 1 in a data subset 49.
  • the transmission is again sent via the Public Switch Telephone Network 44, cellular network station 43 and via wireless communication represented by arrow 50.
  • a received medication set code may also be checked against reference data, which may also include a list of senders authorized to make an authenticity check, for medication set codes from a list, and subsequently an authenticity message containing a result of the authenticity check may be sent in response to the received medication set code.
  • reference data may also include a list of senders authorized to make an authenticity check, for medication set codes from a list, and subsequently an authenticity message containing a result of the authenticity check may be sent in response to the received medication set code.
  • the administration monitoring means which has been described until now may be readily applied in clinical trials where it is essential, for the success of the trial, that the medication be taken as prescribed and for accurate and precise record keeping to be kept.
  • a medication distribution system 50 includes a central storage space 52 in a hospital for storing medication units packaged in blister packs as described above.
  • the storage space 52 is equipped with a bar code reader 54 which is in electronic communication with a central administrator 56 in the hospital.
  • the administrator 56 has a processing unit 58 and a database 60 which is operable to store information relating to the medication in the storage space 52.
  • the system 50 includes a medication transportation means 62, typically a truck 62, also equipped with a barcode reader 64 in electronic wireless communication with a supplier database (not shown) on a supplier's processing unit (not shown). Medication which is loaded onto the truck 62 is barcoded.
  • a medication transportation means 62 typically a truck 62
  • a barcode reader 64 in electronic wireless communication with a supplier database (not shown) on a supplier's processing unit (not shown). Medication which is loaded onto the truck 62 is barcoded.
  • the blister packs are stored in boxes (not shown) of, for example, 100 packs.
  • the boxes are then clustered in containers of, for example 10 boxes.
  • the boxes and containers are barcoded with information of each blister pack contained thereinside.
  • Each barcode is read by the truck's barcode reader 64 when loaded on the truck 62 and the reading is transmitted to the supplier processing unit.
  • the database stores the details of each container.
  • the barcode is again scanned by the barcode reader 64 on the truck 62 and the data is transferred to the processing unit and stored in the supplier database as a function of the date and time of delivery.
  • Each pack delivered is marked on the database as having been delivered. Should the entire truck load not be discharged at the point of delivery, a warning signal may be issued to predetermined parties alerting them to the fact that certain units were removed from the truck during transit.
  • the expiry dates of each medication are stored as this is indicated on the barcode. Also indicated is the active ingredient and the batch number.
  • a health practitioner 66 such as a medical doctor or a dentist, who examines a patient 68 may carry with him a mobile telephone 70, as described above, or a portable computer 72 in electronic communication with the central processing unit 58.
  • Each practitioner who has capacity to prescribe medication in the hospital is given a practitioner identifier code which may be contained in barcode depicted on a wrist band, for example. Instead, it may be an alphanumeric password which may be transmitted to the central processing unit using any of a number of electronic communications means.
  • the processing unit Upon receiving the code, the processing unit is operable to verify the identity of the practitioner. Once the identity has been verified, the practitioner may prescribe medication to the patient.
  • the practitioner 66 enters the patient's identifying code on the computer 72 or the telephone 70 and then the prescription including method of administration.
  • the code and the prescription details are then sent to the central administrator 56 where they are captured in the database 60 against the patient's details. If the patient 68 is already on another medication, the operating system is operable to check the compatibility of it with the newly prescribed medication. If there is any incompatibility, a warning message is transmitted to the practitioner's communication device 70 or 72.
  • a nurse or other assistant Upon reading the prescription, a nurse or other assistant then obtains the relevant medication from the storage space 52 and scans it against the barcode reader 54 at the storage space. The reading is transmitted to the administrator 56 and stored in the central database 60 where the relevant blister pack is marked as "out of storage". The nurse then administers the medication to the patient as described above.
  • the operating unit is operable to transmit a warning signal to a communication device carried by the nurse, such as a mobile telephone or pager.
  • this invention provides a simple yet effective blister pack, which facilitates the taking of medication, by illiterate or semiliterate people.
  • the blister pack also facilitates the tracing of medication units in the event of theft. By providing several different medication units in a pack, the likelihood of theft is also diminished.
  • the method of administering medication increases pharmacovigilance in hospitals.
  • the capturing of data also permits useful statistics relating to the administration of hospitals is kept. This permits for more accurate budgeting and monitoring. Also, the information may be useful for purposes of epidemiological research.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La présente invention concerne une plaquette blister (1) qui comprend un plateau (3) ménageant une pluralité de renfoncements (5), chaque renfoncement (5) recevant une unité de médication (7), et une couverture (9) fixée au plateau (3) afin d'envelopper les unités de médication (7) logées dans les renfoncements (5). Ladite plaquette blister est caractérisée par le fait que les renfoncements (5) reçoivent plus d'un type de médicament. Les médicaments peuvent être destinés au traitement de la même maladie ou au traitement de plus d'une maladie ou affection.
PCT/IB2006/002407 2006-09-01 2006-09-01 Plaquette blister WO2008026020A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002407 WO2008026020A1 (fr) 2006-09-01 2006-09-01 Plaquette blister

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002407 WO2008026020A1 (fr) 2006-09-01 2006-09-01 Plaquette blister

Publications (1)

Publication Number Publication Date
WO2008026020A1 true WO2008026020A1 (fr) 2008-03-06

Family

ID=38017069

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002407 WO2008026020A1 (fr) 2006-09-01 2006-09-01 Plaquette blister

Country Status (1)

Country Link
WO (1) WO2008026020A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011060484A1 (fr) * 2009-11-19 2011-05-26 Scatterbrain Pty Ltd Atf Scatterbrain Trust Procédé et dispositif pour un système de dosage de liquide
GB2483221A (en) * 2010-08-24 2012-03-07 Graham Howieson Mobile phone and camera for dose recognition
WO2014164833A1 (fr) * 2013-03-12 2014-10-09 Meps Real-Time, Inc. Activation passive d'un emballage blister avec un dispositif d'identification sans fil
JP2014528736A (ja) * 2011-06-14 2014-10-30 アプター フランス エスアーエス 流体ディスペンサ装置及び当該装置の製造方法
WO2015114615A1 (fr) * 2014-01-28 2015-08-06 Astra Prime Inc. Kit compact multi-médicaments
FR3031086A1 (fr) * 2014-12-31 2016-07-01 Com4 Dispositif pour recuperer de maniere securisee des comprimes contenus dans une alveole d'un pilulier fermee par une membrane apte a etre perforee.
JP2022172375A (ja) * 2017-05-12 2022-11-15 株式会社湯山製作所 薬剤手撒き装置、薬剤手撒き装置の支援プログラム、および支援プログラムを記録した記録媒体
WO2023194545A1 (fr) * 2022-04-08 2023-10-12 Knapp Ag Emballage de médicament

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043204A1 (fr) * 1998-02-24 1999-09-02 Robert John Humphrey Procedes et systemes permettant de controler l'administration de medicaments a des animaux d'elevage
JP2003245328A (ja) * 2002-02-22 2003-09-02 Kazuto Ando 薬剤の投与・投薬管理システム
WO2003089333A1 (fr) * 2002-04-17 2003-10-30 Boots Healthcare International Limited Dispositif de distribution a partir d'une plaquette
EP1422649A2 (fr) * 2002-11-19 2004-05-26 Dieter Dr. Hafner Procédé pour le contrôle de la prise de médicaments
WO2004103255A2 (fr) * 2003-05-20 2004-12-02 Smithkline Beecham Corporation Plaquettes alveolaires de securite pour enfants utilisant des structures a parois renfermant un medicament
WO2005109948A2 (fr) * 2004-04-24 2005-11-17 Inrange Systems, Inc. Support universel a medicaments
EP1677511A2 (fr) * 2002-07-24 2006-07-05 Sharp Kabushiki Kaisha Dispositif portable, en particulier un téléphone mobile, pour lire des codes à barres et de prise de vue

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043204A1 (fr) * 1998-02-24 1999-09-02 Robert John Humphrey Procedes et systemes permettant de controler l'administration de medicaments a des animaux d'elevage
JP2003245328A (ja) * 2002-02-22 2003-09-02 Kazuto Ando 薬剤の投与・投薬管理システム
WO2003089333A1 (fr) * 2002-04-17 2003-10-30 Boots Healthcare International Limited Dispositif de distribution a partir d'une plaquette
EP1677511A2 (fr) * 2002-07-24 2006-07-05 Sharp Kabushiki Kaisha Dispositif portable, en particulier un téléphone mobile, pour lire des codes à barres et de prise de vue
EP1422649A2 (fr) * 2002-11-19 2004-05-26 Dieter Dr. Hafner Procédé pour le contrôle de la prise de médicaments
WO2004103255A2 (fr) * 2003-05-20 2004-12-02 Smithkline Beecham Corporation Plaquettes alveolaires de securite pour enfants utilisant des structures a parois renfermant un medicament
WO2005109948A2 (fr) * 2004-04-24 2005-11-17 Inrange Systems, Inc. Support universel a medicaments

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011060484A1 (fr) * 2009-11-19 2011-05-26 Scatterbrain Pty Ltd Atf Scatterbrain Trust Procédé et dispositif pour un système de dosage de liquide
GB2483221A (en) * 2010-08-24 2012-03-07 Graham Howieson Mobile phone and camera for dose recognition
JP2014528736A (ja) * 2011-06-14 2014-10-30 アプター フランス エスアーエス 流体ディスペンサ装置及び当該装置の製造方法
WO2014164833A1 (fr) * 2013-03-12 2014-10-09 Meps Real-Time, Inc. Activation passive d'un emballage blister avec un dispositif d'identification sans fil
WO2015114615A1 (fr) * 2014-01-28 2015-08-06 Astra Prime Inc. Kit compact multi-médicaments
FR3031086A1 (fr) * 2014-12-31 2016-07-01 Com4 Dispositif pour recuperer de maniere securisee des comprimes contenus dans une alveole d'un pilulier fermee par une membrane apte a etre perforee.
WO2016107898A1 (fr) * 2014-12-31 2016-07-07 Com4 Dispositif pour recuperer de maniere securisee des comprimes contenus dans une alveole d'un pilulier fermee par une membrane apte a être perforee
JP2022172375A (ja) * 2017-05-12 2022-11-15 株式会社湯山製作所 薬剤手撒き装置、薬剤手撒き装置の支援プログラム、および支援プログラムを記録した記録媒体
JP7307386B2 (ja) 2017-05-12 2023-07-12 株式会社湯山製作所 薬剤手撒き装置、薬剤手撒き装置の支援プログラム、および支援プログラムを記録した記録媒体
WO2023194545A1 (fr) * 2022-04-08 2023-10-12 Knapp Ag Emballage de médicament

Similar Documents

Publication Publication Date Title
US10357428B2 (en) Medication organizer tray apparatus
WO2008026020A1 (fr) Plaquette blister
US6961285B2 (en) Drug delivery management system
US6994249B2 (en) System and method for drug management utilizing transferable labels
US11443840B1 (en) Medication adherence apparatus
EP1507227A2 (fr) Améliorations liées à des systèmes de gestion d'informations
AU2004221133A1 (en) System and method for presenting and distributing medication information
US20100179824A1 (en) Management system for prescribing/dispensing medicine which may cause serious side effect
US11481739B1 (en) Medication disposal, treatment and reconciliation kiosk device
JP2009125386A (ja) 服薬アラームシステム
US20080091475A1 (en) Medication management and record access system
CN109559795B (zh) 基于数据处理的违规处方单的检测方法及相关设备
JP2018175297A (ja) 薬剤配置確認システム、薬剤配置確認方法並びに薬剤配置確認プログラム
JPWO2003103564A1 (ja) 調剤の検品方法及び調剤検品システム
KR102555368B1 (ko) 정보영역을 갖는 약품, 상기 약품을 통한 정보제공시스템
EP3893244A2 (fr) Procédé de fourniture d'informations sur des médicaments
JP2016212822A (ja) 薬剤管理システム及び薬剤管理サーバ
CN112992322A (zh) 一种手术用品的取用方法及***
TW201009633A (en) Method and system for reducing medication error rate
Gurtel et al. PHAMIS pharmacy system
Schulze PDL risk management: Dispensing errors-too much or not enough

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06795400

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06795400

Country of ref document: EP

Kind code of ref document: A1